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Effects of Chelating Agents on Oral Uptake
and Renal Deposition and Excretion of
Cadmium
by Birgitta Engstrom*
The gastrointestinal absorption, transport, tissue deposition and excretion ofcadmium
was studied in adult male mice given a single oralLD50 dose ofl19Cd-labeled CdCl2 alone
or in combination with nitrilotriacetic acid (NTA), sodium tripolyphosphate (STPP) or
ethylenediaminetetraacetic acid (EDTA). Blood, intestinal mucosa, liver and kidneys
were analyzed for lO9Cd at different times after exposure and the influence of the
chelating agents on Cd binding to metallothionein and other tissue ligands was also
studied. Acute toxicity was noted.
Complex formation between Cd and EDTA was studied in solutions containing
Cd:EDTA at 1:04 and 1:4 molar ratios. Adult male mice were exposed orally or by direct
infusion into the stomach to either ofthe two solutions (containing anLD50 dose of Cd).
Body retention and tissue deposition of Cd was recorded after 4 (direct infusion) or 21
days (oral exposure), and the mortality in different exposure groups observed.
Adult male were also exposed to a low oral dose ofl19Cd-labeled cadmium (0.5 mg/kg),
followed by 18 months continuous administration of NTA, (500 ppm) STPP (500 ppm) or
EDTA (50 ppm) in the drinking water or the chelating agent in combination with Cd (50
ppm), Cd alone (50 ppm) or deionized water. Whole-body retention of l19Cd, tissue
deposition oflO9Cd and total Cd and development ofproteinuria were observed.
When cadmium was given with an excess ofEDTA, all Cd ions were bound in a 1:1 Cd-
EDTA complex. Decreased acute toxicity was observed which was related to increased
body elimination ofcadmium. The Cd passes though the body still bound to EDTA and is
excreted via the kidneys in this form. Similar results were found in mice exposed to
Cd+NTA, while gavage ofCD+STPP led to an initially decreased systemic uptake ofCd
and thereafter to a prolongation of the biological half-time and thus a comparatively
higher body retention ofthe metal.
Cdmayform a2:1complexwithEDTAinthepresenceofexcesscadmium. Anincreased
retention and toxicity of cadmium was seen after direct infusion of this solution, while
gavage resulted in a decreased toxicity. The effect ofdifferent chelating agents on acute
cadmium toxicity and metabolism seemed to be due to changes in the stability of the
administered chelate complexes, due to variation in pH and to the availability of metal
binding ligands such as metallothionein in vivo. NTA, STPP and EDTA had no effect on
the metabolism or toxicity ofcadmium after long-term low dose oral exposure.
Introduction
The role of chelating agents in heavy metal
metabolism andtoxicity has been much discussed
and subjected to several investigations. Due to its
metal-binding properties, EDTA has found wide
application in several fields and is also used as an
antidote for metal poisoning in human beings (1).
Several studies have shown that EDTA is supe-
rior to BAL (British Anti-Lewisite) in the protec-
tion against acute cadmium poisoning in animals
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(2-). However, EDTA is also known to be poten-
tially nephrotoxic to animals (4,7-10), and renal
lesions have been observed in human beings
given chelation therapy with EDTA against lead
poisoning (11,12). Other toxic effects including
hepatic lesions and degenerative changes in the
intestinal cells have also been reported
(10,13,14). EDTA can further exert adverse ef-
fects by forming complexes with many essential
metals in the body (such as Ca, Mg, Cu and Zn),
resulting in alterations ofthe homeostasis ofcal-
cium in humans (15) and teratogenic effects in
rats due to zinc deficiency (16). It has been re-Table 1. Designs ofthe various experiments reviewed in this chapter.
Single dose of Cd or
Routes ofsingle Single dose chelating chelating
exposure to ofcadmium, agents, agents in
Experi- Groups and number radioactive dose/kg body dose/kg drinking water Time of
ment ofanimals (sex) cadium weight body weight (ppm) observation
I 4+4+4+4 (M) Oral 60 mg 5 min
4+4+4+4 (M) " 60 mg 600 mg NTA 30 min
4+4+4+4 (M) " 60 mg 600 mg STPP 1 hr
4+4+4+4 (M) " 60 mg 600 mg EDTA 5 hr
II 4 + 9 (M) Oral 60 mg
4 + 9 (M) " 60 mg 60 mg EDTA
4 + 9 (M) " 60 mg 600 mg EDTA
(3+3+4) (M) Direct infusion 60 mg 1+5+96 hr
(3+3+4) (M) into the stomach 60 mg 60 mg EDTA
(2+2+2) (M) 60 mg 600 mg EDTA
5 (M) 0.9%NaCl
(controls) 14 days
III 4 + 9 (M) Oral 60 mg
4 + 9 (M) " 60 mg 600 mg NTA 5hr +
4 + 9 (M) " 60mg 600 mgSTPP 21 days
IV a 8+8 (F) Oral 15 gga
b 8+8 (F) " 15 gga Cd 50
c 8+8 (F) n 15 gga NTA 500
d 8+8 (F) it 15jga Cd + NTA50+500 18 months
e 8+8 (F) n 15jga STPP 500
f 8+8 (F) " 15jga Cd + STPP 50+500
g 8+8 (F) " 15 Iga EDTA50
h 8+8 (F) " 15 tga Cd + EDTA50+50
aDose/animal.
ported in animal experiments that simultaneous
exposure to Cd and EDTA by subcutaneous injec-
tion markedly reduced cadmium retention in kid-
ney (4,5) andresulted in increased urinary excre-
tion of cadmium about 500-fold (4). However,
when EDTA was administered some time after
the Cd dose, the effect ofthe chelating agent was
less dramatic (4,17). These results indicate that
EDTAcannot interfere when the metal is already
bound to metallothionein inthe tissue. EDTA has
also been shown to enhance the gastrointestinal
absorption of lead (18-21) which has also been
seenforcadmium(22) in in vitroperfusion studies
onratintestine. In contrastto these observations,
decreasedabsorption ofcadmiumfromthe gastro-
intestinal tract of rats has been reported after
direct infusion of Cd-EDTA into the duodenum
(23).
The common use ofeither NTA (nitrilotriacetic
acid) or STPP (sodium tripolyphosphate) in mod-
ern detergents resulted in studies to clarify the
role of these chelating agents in heavy metal
toxicity. NTA was shown to increase the acute
toxicity of cadmium in rats when administered
together with the metal as a single subcutaneous
dose (24). This was later confirmed in studies on
mice (25), where also STPPgiven subcutaneously
with Cd increased the acute toxicity ofthe metal
due to extensive necrotic changes in the livers of
the exposed animals (25). In contrast to these
results, NTA given orally together with cadmium
has been shown to reduce deposition ofcadmium
inliver, kidney andmuscle in rats andto increase
urinary and fecal excretion of cadmium (26,27),
thereby reducing the toxic effects of the metal.
The reason for the different effect ofNTA, which
is influenced by the route of administration, is
probably a change in stability ofthe chelate com-
plex. It has been shown that the toxic effects of
many metals in vivo depend on the metal: chelant
ratio (28) due to a competition between the che-
lating agent and various tissue ligands for the
metal ion.
The present paper summarizes some further
resultsfrom experiments on mice concerninggas-
trointestinal absorption, transport, tissue deposi-
tion and excretion of cadmium after single and
repeated exposure alone or in combination with
either EDTA, NTA or STPP.
Methods
Experimental Design
CBA mice, inbred for more than 200 genera-
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tions (Institute of Genetics, Stockholm Univer-
sity), were used in all experiments. In the long-
term experiment, animals of both sexes were
studied (Table 1). The other experiments were
performed on male mice, since, in pilot studies of
the LD50 ofcadmium, male mice were found more
susceptible to adverse effects of cadmium com-
pared to females. Animals were housed in plastic
cages at a constant light and dark cycle, with a
temperature of 200C. Air humidity varied be-
tween 25 and 40%. The animals were fed an
ordinary pelleted diet and had free access to de-
ionized water. All animals were 3 months of age
at the beginning ofeach experiment.
Chemicals
Acarrier-free solution of109CdCl2 (T112 = 1.3 yr,
Radio-Chemical Center, Amersham, U.K.) was
mixed with nonradioactive cadmium chloride in
such proportions that concentration and activity
wouldfitthepurpose ofeachstudy(listed inTable
1).
The chelating agents EDTA, NTA and STPP
were administered alone or simultaneously with
cadmium as asingle dose eitherby gavage (exper-
iments I and III) or by direct infusion into the
stomach (experiment II), or given in the drinking
water for 18 months (experiment IV). Routes of
exposure and concentration of chelating agents
and cadmium used in each experiment are given
in Table 1.
Complex Formation between Cd(II)
and EDTA
The complex formation between Cd (II) and
EDTA was determined by a potentiometric
method in solutions containing varying amounts
of cadmium (6-50 mmole/L) and EDTA (1-100
mmole/L) in a pH range from 1.8 to 6.5. Stability
constants for the formation of several complexes
(including Cd-EDTA and Cd2-EDTA) were evalu-
ated and equilibrium distribution of the various
complexes formedbetween Cd(II) and EDTA (as a
function ofpH and the concentration ofcomplex-
forming components) was calculated in the solu-
tions used for animal exposure in experiments I
and II. Further details concerning these mecha-
nisms are given in a separate publication (29,30).
Metal Analysis
Radiolabeled Cadmium (O9Cd). Whole-body
and organs was measured by use ofgamma scin-
tillation spectrometry (29).
In experiment I the duodenum and small intes-
tine were removed immediately after sacrifice,
cut open and carefully washed with isotone sa-
line. The concentration ofradiolabeled cadmium
in these organs was also determined by gamma
scintillation spectrometry with a Nuclear Chi-
cago 8742 Autogamma counting system. All
countings were compared to appropriate stan-
dards containing a defined amount of 109Cd-la-
beled cadmium.
Whole blood (about 0.5 mL/animal) was taken
from mice in experiment I by heart puncture
under light ether anesthesia immediately before
sacrifice, and centrifuged for 2 min at 20,000 rpm
in a microcentrifuge. The concentration of ra-
diolabeled cadmium was determined in whole-
blood, plasma and red cells according the tech-
nique described above for organ samples.
Total Concentration of Metals (Cd and Zn).
Metal concentrations in all solutions used for
exposure were analyzed by flame atomic absorp-
tion spectrometry (AAS) as described by Elinder
et al. (31).
Total concentrations of cadmium and zinc in
liver, kidney, kidney cortex and pancreas (experi-
ment IV) were determined by flame-AAS or, in
pig/g Cd
5 30 60 minutes 5 hours
FIGURE 1. Concentration ofcadmium inwholeblood atdiffer-
ent times after a single oral dose of cadmium alone or in
combination with chelating agents: (A) Cd + EDTA; (o)
Cd; (0) Cd + NTA; (U) Cd + STPP. Bars denote standard
error.
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FIGURE 2. Distribution ofcadmium among mouse plasma proteins 30 min after exposure to a single oral dose of: (A) Cd alone, (B)
Cd + NTA, (C) Cd + STPP or (D) Cd + EDTA: (-) l09Cd-labeled cadmium in 5 mL fraction; (-) 0. D. at 254 nm.
cases oflow metal content, heated-graphite atom-
izer (HGA)-AAS was used after dry ashing (32).
The accuracy of the cadmium analysis in tis-
sues has been controlledby measurements ofcad-
mium in reference materials (NBS liver and Or-
chard leaves). Furthermore, comparison with
other laboratories using AAS or neutron activa-
tion analysis has shown consistent results (33).
Analytical Technique for Studying
Metal Protein Binding
Preparation of tissue samples (duodenum and
small intestine, experiment I; liver and kidneys,
experiments II-III) for analysis of content and
distribution of cadmium among different pro-
teins, included homogenization, ultracentrifuga-
tion and separation ofthe organ supernatants on
a G-75 Sephadex column. Fractions of5 mL were
eluted with 0.01 M Tlis-HCl buffer. In experi-
ment I, samples of duodenum from two mice in
the same exposure group were pooled and ana-
lyzed accordingly.
Plasma samples from two mice in the same
exposure group (experiment I) were pooled and
separated on a G-75 Sephadex column infractions
of 5 mL by elution with 0.01 M Tris-HCl buffer.
The contentofradiolabeledcadmium in each frac-
tion was determined by gamma scintillation
counting as described above for organs.
The G-75 Sephadex column used for separation
ofproteins was calibratedusing aprotein calibra-
OD.
45 Fraction NQ
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tion kit with proteins of specified molecular
weights (29,34).
Evaluation ofProteinuria
Proteinuria (experiment IV) was determined
qualitatively and quantitatively according to the
method described by Nordberg and Piscator (35).
Adensitometer was usedfor evaluationofelectro-
phoretic patterns. Patterns having a 3-globulin
scanned surface exceeding 8% ofthe prealbumin
scanned surface were classified as suspectedpath-
ological, and patterns with a 3-globulin area ex-
ceeding 24% of the peak with the largest area
were designated as clearly pathological proteinu-
ria. These figures are in approximate agreement
with the 3-peak heights of 10% or 30% of the
highest peak in patterns designated as suspected
or clearly pathological by Nordberg and Piscator
(35).
Statistical Analysis
The Student's t-test was used to calculate the
significance of differences in metal content in
organs ofmice in different exposure groups. Anal-
ysis ofvariance was used for calculation ofstatis-
tically significant differences ofthe same parame-
ters among several groups. When comparing
pg/g Cd
pg Cd in 5ml fraction
Fraction No.
FIGURE 3. Distribution of radiolabeled cadmium in 5 mL
fraction after separation ofthe different solutions used for
animal exposure on a G-75 Sephadex column:
(a--) Cd; (9-) Cd + EDTA; (o--) Cd + NTA; (o-) Cd +
STPP.
pg/g Cd
A
S 30 60 minutes 5 hours 5 30 60 minutes
FIGURE 4. Concentration ofcadmium in (A) duodenum and (B) small intestine ofmice atdifferent times after exposure to a single
oral dose ofcadmium alone or in combination with chelating agents. Symbols as in Fig. 1.
B
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groups of less than five animals in each the
Mann-Whitney U-test and Kruskal-Wallis one-
way analysis ofvariance byranks were used (36).
Results
Acute Exposure
Absorption andTr-ansportinBlood. Cadmium
concentrations in whole blood during the first
hours after asingle oral dose ofcadmium alone or
in combination with either EDTA, NTA or STPP
(experiment I) are shown in Figure 1. At 5 and 30
min after exposure, twice as high blood cadmium
concentrations were observed in mice given Cd +
EDTA and Cd + NTAcomparedtothose given Cd
alone. However, at 1 and 5 hr after exposure no
such differences were seen among these groups.
At all times ofobservation, lower concentrations
of cadmium in blood were observed in mice ex-
posed to Cd + STPP compared to all other expo-
sure groups.
Cadmium wasrecovered mainly in plasma dur-
ing the first hours following exposure. The distri-
bution of cadmium among plasma proteins 30
min after exposure is seen in Figure 2. After
exposure to Cd alone or Cd + STPP (Fig. 2A and
2C), cadmium was eluted together with high mo-
lecularweightproteins. Mice exposedtocadmium
in combination with either NTA or EDTA (Figs.
2B and2D)hadasubstantialpartofthe cadmium
bound in the respective chelate complexes as well
(see Fig. 3). Distribution ofcadmium in plasma 5
and 60 min after exposure was similar to that
observed after 30 min.
Tb gain further information about the mecha-
nisms by which these chelating agents act in the
transport ofcadmium from the intestine toblood,
the concentration and distribution ofcadmium in
the intestinal mucosa was studied. Generally,
higher concentrations of cadmium were seen in
the duodenal mucosa (Fig. 4A) compared to the
that of small intestine (Fig. 4B). Maximum cad-
mium concentrations in the intestinal mucosa
wasnotedbetween 5 and30 minafterexposure in
all mice. Cadmium distribution among proteins
in the mucosa of the small intestine was deter-
mined 30 min and 5 hr after exposure by gel
chromatography, and the results are given in
Figure 5. Mice exposed to cadmium alone or CD
+ STPPhadthe main partofthe cadmium inthe
intestinal mucosa bound to high molecular
weight proteins 30 min after exposure (Fig. 5A
and 5C). Cadmium in the Cd + STPP-exposed
mice was also partly eluted with a low molecular
weight protein. Mice given Cd + NTA or Cd +
EDTA had most cadmium bound in the chelate
form (Fig. 3) in the intestinal mucosa 30 min
after exposure (Figs. 5B and 5D).
At 5 hr after exposure, a general transfer of
mucosal cadmium from the high to a low molecu-
lar weight protein was seen in all ofthe exposed
mice (Figs. 5E-H). The molecular weight of this
protein was estimated to about 10,000 daltons,
which corresponds to that ofmetallothionein ob-
served after gel chromatography (37). Thus, in
spite of no further characterization, this protein
will be called metallothionein in the following
text.
Retention andDistribution. In experiment II,
mice were exposed to single doses ofCdCl2 alone
or in combinationwithvarying amounts ofEDTA
[in Cd(II)EDTA molar ratios of 1:0.4 or 1:4, re-
spectively], either via stomach tube (gavage) or
by direct infusion into the stomach. At 1, 5, 24
and 96 hr after exposure the retention of cad-
miuminliver andkidneywasdetermined. Distri-
bution of cadmium among proteins in these or-
gans was also studied 5 hr after exposure.
At 1 hr after gavage the liver/kidney cadmium
concentration ratio was about 1:0.25 in mice
given Cd alone, about 1:0.5 in mice given Cd +
EDTA (1:0.4) and about 1:1 in mice given Cd +
EDTA (1:4).
About four times higher cadmium concentra-
tions were found in liver and kidney 1 hr after
direct infusion into the stomach compared to
gavage (p < 0.05) (Table 2). Mice exposedto Cd +
EDTA (1:0.4) by direct infusion had more than
twice as high liver cadmium concentrations and
almostfive timeshigher kidney cadmium concen-
trations 1 hr after exposure compared to mice
given Cd alone (p < 0.05), while mice given Cd +
EDTA (1:4) had very low concentrations of cad-
mium in these organs.
In order to obtain an explanation of these
results, the complexation between Cd(II) and
EDTA was determined in the different solutions
used for exposure. In the solution with an excess
ofEDTA in relationto cadmium, almost all Cd(II)
ions were boundto EDTA in a stable 1:1 complex,
Cd-EDTA (with a logarithmic stability constant
of15.30 ± 0.04) (Fig. 6).
ItwasfurthershownthatEDTAmayforma 2:1
complex Cd2-EDTA (with a logarithmic stability
constantof16.58 + 0.07) inthepresence ofexcess
cadmium. This binuclear complex accounted for
about 35% of all complexes in the Cd + EDTA
(1:0.4) solution within the pH range 4-7 (Fig. 6).
The rest of the Cd(II) ions in this solution were
either free (about 45%) or bound in a 1:1 complex
with EDTA (about 20%). Further details about
complexesformedbetween Cd(II) andEDTAhave
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FIGURE 5. Distribution ofcadmium amongproteins in mouse small intestinal mucosa (A-D) 30 min or (E-H) 5 hr after a single
dose ofCd alone, Cd + NTIA, Cd + STPP or Cd + EDTA, respectively. Symbols as in Fig. 2.
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SOCTable 2. Concentrations ofcadmium in organs ofmice 1 hr after a single dose ofCd alone or Cd in combination with
various amounts ofEDTA by either oral exposure or direct infusion into the stomach (under narcosis).
Cd concn, mg/kg
Oral exposure Direct infusion
Groups
(molar ratio) Liver Kidneys n Liver Kidneys n
Cd MV 16.34 5.47 4 MV 68.47 29.48 3
SD 6.80 2.32 SD 3.02 6.60
Cd + EDTA MV 6.42 3.30 4 MV 158.54 151.07 3
(1:0.4) SD 3.42 1.70 SD 60.97 55.77
Cd + EDTA MV 10.10 10.52 4 MV 5.43 8.12 2
(1:4) SD 4.11 6.17 SD 0.60 1.38
been reported by Engstrom et al. (29) andJawaid
(30).
The distribution ofcadmium different proteins
in liver andkidney was determined at all times of
sacrifice. At 1 hr after exposure, most cadmium in
the liver ofall mice was bound to high molecular
weight proteins. Mice exposed to Cd alone had
most cadmium in kidneys bound to high molecu-
lar weight proteins (Fig. 7). Almost all cadmium
in kidneys of mice exposed to Cd + EDTA (1:4)
was bound in the Cd-EDTA complex, while only
part of the cadmium given in the Cd + EDTA
(1:0.4) solution was bound to the chelant, and the
rest bound to high molecular weight proteins. An
increased 24-hr elimination ofcadmium was seen
when given together with EDTA, which ac-
counted for about 45% of the dose in mice given
Cd + EDTA (1:4), about 35% in mice given Cd +
EDTA (1:0.4) compared to only about 20% in mice
given Cd alone.
At 5 hr after exposure, mice given Cd + EDTA
had more Cd bound to metallothionein in the
liver than mice given Cd alone (Figs. 8A-C). The
distribution of cadmium among proteins in the
kidneys after gavage ofCd + EDTA did not show
any marked differences to that of Cd alone, i.e.,
the largest part was recovered in the high molec-
ular weight protein fractions, except for a minor
peak corresponding to the elution of the com-
plexes (Figs. 8D-.F).
In another study (experiment III) the influence
ofNTA and STPP on cadmium retention in liver
and kidney ofmice was studied 5 hr and 21 days
following single oral doses ofCd alone or in com-
bination with the respective chelating agents.
At 5 hr afterexposure no difference inretention
ofcadmium was seen among mice given Cd alone
or Cd + NTA while animals given Cd + STPP
had accumulated less cadmium (about one-third
in liver and one-fifth in kidney) compared to mice
given Cd alone (p < 0.001).
The subcellular distribution of cadmium in
liver and kidney 5 hr after exposure showed that
more of the total liver cadmium in mice given
given Cd + STPP was found in the supernatant
fraction (about 60%) compared to 35-40% in mice
given either Cd + NTA or Cd alone. A similar
distribution pattern was also observed in the kid-
neys. Mice exposed to Cd + NTA had relatively
more cadmium bound to high molecular weight
proteins in the liver compared to that seen in
mice given Cd alone (Figs. 9A and B). Cadmium
given in combination with STPP was mainly re-
covered in the metallothionein fraction (Fig. 9C).
Most cadmium in kidney of all mice was bound
mol%
FIGURE 6. Mole per cent distribution of different Cd-EDTA
complexes as a function of pH in solutions with different
concentrations ofCd (II) and EDTA, respectively: (-) Ccd
= 8.90 x 10-2,CEDTA = 3.42 x 10-2M;(--)CCd = 8.90 x
10-2, CEDTA = 0.342 M.
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FIGURE 7. Distribution ofcadmium among mouse kidney proteins,
+ EDTA (1:0.4) or (C) Cd + EDTA (1:4). Symbols as in Fig. 2.
mainly to high molecular weight proteins. Cd +
NTA-exposed mice (Fig. 9E) did also have a prom-
inent radioactive Cd-peak corresponding to the
elution volume ofthe chelate complex.
Between 5 hrand 21 days after exposure, a 3- to
5-folddecrease inthe cadmium concentration was
observed in liver and kidney ofmice given Cd +
NTA, while mice given Cd + STPP on the con-
trary showed about a 2-fold increase of the cad-
mium concentration in liver and about a 7-fold
increase in kidney (p < 0.001).
No marked change in the cadmium concentra-
tion was seen during this period in mice given Cd
alone. The observed 21-day whole-body retention
was 4.4% ofthe dose in mice given Cd alone, 2%
in mice given Cd + NTA and 5.5% in mice given
Cd + STPP.
Repeated Exposure
In experiment IV mice were given a single oral
dose of109Cd-labeled cadmium. Some groups were
thereafter administered continuous low doses of
nonradioactive cadmium alone or in combination
1 hrafter exposure to (A) a single oral dose ofCd alone, (B) Cd
with NTA, STPP or EDTA, in drinking water for
18 months. Other mice were given deionized wa-
ter or water with addition ofNTA, STPP or EDTA
(see Table 1).
The total concentration of cadmium and zinc
was determined in liver, kidney, kidney cortex
and pancreas at sacrifice. The concentration of
cadmium was highest in kidney cortex (120-160
gg/g) of all mice given cadmium in the drinking
water. These animals also had higher organ con-
centrations of zinc. However, no substantial dif-
ferences in whole-body or organ retention of
either radioactive or nonradioactive cadmium
were seen among groups after treatment with
chelating agents.
Toxicity
The acute and chronic toxicity ofcadmium was
studied (by means of mortality rates) in all of
these experiments forwhich metabolismhasbeen
described above.
Acute 7bxicity. Nomortality was seeninmice
exposed to cadmium, and an excess of EDTA by
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FIGURE 8. Distribution ofcadmium among proteins in (A-C) mouse liver and (D-F) kidneys 5 hr after exposure to a single oral
dose ofCd alone, Cd + EDTA (1 = 0.4) or Cd + EDTA (1:4), respectively. Symbols as in Fig. 2.
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FIGURE 9. Distribution ofcadmium among proteins in (A-C) mouse liver and (D-F) kidneys 5 hr after exposure to a single oral
dose ofCd alone, Cd + NTA or Cd + STPP, respectively. Symbols as in Fig. 2.
either route of exposure (gavage or direct infu-
sion). Administration of Cd + EDTA (1:0.4) re-
sulted in a mortality rate of 0% (after oral expo-
sure) and 75% (after direct infusion), while in
mice exposed to Cd alone, the rate was 45% and
100%, respectively. The times of observation are
given in Table 3.
Single oral exposure to Cd + NTA did not
influence the toxicity of cadmium, while gavage
of Cd + STPP markedly reduced toxicity of cad-
mium.
Chronic Tbxicity. Mortality in experiment IV
was not increased in groups given cadmium in
combination with chelating agents compared to
those given Cd alone.
The number ofmice showing pathological pro-
teinuria increasedduringthe last 9 months ofthe
study, but only one of the Cd-exposed animals
developed clearly pathological proteinuria. This
low frequency may be due to the fact that the
total cadmium concentration in the kidney cortex
was below 200 ug/g the level at which tubular
dysfunction has been reported to appear in mice
(35).
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-0Table 3. Mortality in mice after single exposure to Cd alone or in combination with chelating agents by different
routes ofexposure.
Groups Route of Mortality rate at various times
(molar ratio) exposure 5 hr 24 hr 96 hr 21 days
Cd Oral 0/13 4/9 4/9 4/9
Cd + NTA (1:6) " 0/13 4/9 4/9 4/9
Cd + STPP (1:3) " 0/13 0/9 0/9 0/9
Cd + EDTA (1:0.4) " 0/8 0/4
Cd + EDTA (1:4) " 0/8 0/4 -
Cd Stomach infusion 4/7 4/4 4/4
Cd + EDTA (1:0.4) " 2/7 3/4 3/4
Cd + EDTA (1:4) " 0/4 0/2 0/2
NaCl (controls)a t 0/5 0/5 0/5
aNo mortality was found in these mice during an observation time of14 days.
Chelating agents given in combination with
cadmium did not increase the frequency ofeither
suspected or clearly pathological proteinuria.
Discussion
The decrease in acute cadmium toxicity ob-
served in the mice given Cd and an excess of
EDTA (by various routes of administration) was
related to an increased body elimination of cad-
mium. A similar observation in rats has previ-
ously been reported after subcutaneous exposure
(4). Since all Cd(II) ions in the administered solu-
tion were bound to EDTA in a 1:1 Cd-EDTA
complex, it is possible that most cadmium was
excreted via urine while still bound in this com-
plex with EDTA. Further support for this as-
sumption is provided by data showing that cad-
mium was transported in blood mainly bound to
EDTA and the high accumulation of cadmium
bound to EDTA in the kidneys 1 hr after oral
exposure. In spite of a higher gastrointestinal
absorption of cadmium, also reported for lead
(18-21) the body burden of cadmium was de-
creased after oral exposure to Cd + EDTA (1:4).
This was due to the increased elimination of ab-
sorbed cadmium, which has also been shown for
lead (21).
In spite ofthe fact that most Cd(II) is detached
from EDTA in the low pH of the stomach after
oral exposure, the 1:1 Cd-EDTA complex isproba-
bly re-established in the intestine in the presence
of excess EDTA. It is further probable that the
weak Cd2-EDTA complex is not re-established in
the intestine in the presence of mucosal ligands
with large metal-binding capacities. However,
some 1:1 Cd-EDTA complexes will probably be
found which may explain the low toxicity ofcad-
mium following oral exposure in these mice.
The reasonfor an increasedretention andtoxic-
ity ofcadmium following direct infusion ofCd +
EDTA (1:0.4) is not fully understood. However, it
can be assumed that the complexes in this solu-
tion will pass intact via the stomach into the
intestinal lumen, since the gastric secretion of
hydrogen ions is decreased under Mebumal nar-
cosis (38,39). Fewerhydrogen ions are thus avail-
able to compete with cadmium for the binding to
EDTA. Furthermore as the Cd2-EDTA complex is
uncharged, itwillpenetrate cell membranesmore
easily and thereby cause an increased body accu-
mulation of cadmium. The increased accumula-
tion in liver might exceed the upper limit for the
metallothionein synthesis in response to cad-
mium, which has been shown to be dose-related
after single intraperitoneal dosesupto 3 jgCd/kg
body weight (40). When metallothionein is not
available in quantities large enough to bind cad-
mium, the metal may cause tissue damage. This
would be a probable explanation for the high
mortality in the Cd + EDTA (1:0.4)-exposed mice
following direct infusion.
The toxicity of cadmium after gavage of Cd
alone and Cd + NTA was the same, while expo-
sure to Cd + STPP caused a markedly decreased
toxicity. Gastrointestinal absorption was in-
creased by NTA and, as was the case in Cd +
EDTA (1:4)-exposed mice, part of the cadmium
was still bound to the chelant in intestinal mu-
cosa andblood. Accordingtowhole-bodymeasure-
ments, total elimination of cadmium was en-
hanced by NTA. Since most kidney cadmium was
bound to NTA 5 hr after exposure, the main route
ofelimination is probably via urine.
STPP, on the other hand, decreased the sys-
temic uptake of cadmium during the first hours
after exposure, as demonstrated by the low blood
concentrations ofcadmium in these mice. As the
polyphosphate is being hydrolyzed into
monophosphate in the low pH in the stomach, an
insoluble cadmium orthophosphate salt (41) is
probably formedbycadmium andmonophosphate
in the intestinal lumen. This would explain the
lower absorption of cadmium following this type
230 B. ENGSTROMEFFECTS OF CHELATING AGENTS 231
of exposure. The longer retention time of cad-
mium in the intestinal mucosa ofmice given Cd
+ STPP is probably related to the binding of
cadmium to intestinal metallothionein.
Most cadmium in the liver was already bound
to metallothionein 5 hr after oral exposure to Cd
+ STPP. This may be due to the fact that a very
low amount ofcadmium was initially absorbed in
these mice. Relatively more cadmium probably
binds to metallothionein already present in the
liver. The relatively high cadmium content in the
liver supernatant fraction 5 hr after oral expo-
sure to Cd + STPP, compared to the other groups,
also sustains this hypothesis. The binding ofcad-
mium to metallothionein in the liver which is
known to prolong the biological half-time of cad-
mium (42,43) would explain the higher 21-day
body retention of cadmium in mice given Cd +
STPP compared to Cd alone. Another explanatiori
for this might be that the mice retaining the
highest amounts of cadmium after gavage of Cd
alone died within the 21-day period.
Body retention and toxicity following long-
term oral low-level cadmium exposure was not
shown to be influenced by either chelating agent
during an observation time of 18 months. This
may be due to an inability ofchelating agents to
interfere with cadmium already bound to metal-
lothionein in tissue.
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